Log in to your Inderes Free account to see all free content on this page.

Bavarian Nordic

188.00 DKK

+2.37 %

Less than 1K followers

BAVA

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+2.37 %

+2.15 %

-18.40 %

+6.79 %

-0.71 %

-2.84 %

-9.66 %

-4.28 %

+31.81 %

Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Market cap

14.9B DKK

Turnover

51.55M DKK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

All

Research

Webcasts

Press releases

ShowingAll content types

Regulatory press release4 hours ago

Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees

Bavarian Nordic

Press releaseyesterday

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic

Bavarian Nordic

Regulatory press release12/2/2025, 7:01 AM

Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million

Bavarian Nordic

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Press release11/26/2025, 8:00 PM

Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen

Bavarian Nordic

Regulatory press release11/14/2025, 6:37 AM

Bavarian Nordic Announces Interim Results for the First Nine Months of 2025

Bavarian Nordic

Regulatory press release11/13/2025, 7:45 PM

Bavarian Nordic Announces Changes to the Board of Directors

Bavarian Nordic

Regulatory press release11/10/2025, 8:00 PM

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic

Regulatory press release11/7/2025, 4:30 PM

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic

Regulatory press release11/6/2025, 2:03 PM

Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed

Bavarian Nordic

Regulatory press release11/5/2025, 7:30 AM

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic

Regulatory press release11/4/2025, 7:30 AM

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic

Press release11/1/2025, 9:34 AM

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business

Bavarian Nordic

Regulatory press release10/31/2025, 2:56 PM

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic

Regulatory press release10/31/2025, 1:07 PM

Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira

Bavarian Nordic

Regulatory press release10/31/2025, 8:14 AM

Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox

Bavarian Nordic

Regulatory press release10/29/2025, 12:29 PM

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic

Press release10/28/2025, 7:30 AM

Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines

Bavarian Nordic

Regulatory press release10/21/2025, 12:46 PM

Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic

Bavarian Nordic

Regulatory press release10/16/2025, 5:27 AM

The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira

Bavarian Nordic

Regulatory press release10/15/2025, 3:57 PM

Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic

Bavarian Nordic

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.